We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$112M
AUM Growth
-$13.3M
Cap. Flow
-$5.94M
Cap. Flow %
-5.31%
Top 10 Hldgs %
38.7%
Holding
66
New
2
Increased
18
Reduced
11
Closed
9

Top Buys

1
HAS icon
Hasbro
HAS
+$1.31M
2
CPA icon
Copa Holdings
CPA
+$1.19M
3
FCX icon
Freeport-McMoran
FCX
+$895K
4
OGN icon
Organon & Co
OGN
+$815K
5
PAAS icon
Pan American Silver
PAAS
+$671K

Top Sells

1
KD icon
Kyndryl
KD
+$3.22M
2
PFE icon
Pfizer
PFE
+$1.74M
3
HRI icon
Herc Holdings
HRI
+$1.28M
4
PRGO icon
Perrigo
PRGO
+$1.05M
5
WBD icon
Warner Bros
WBD
+$976K

Sector Composition

1 Healthcare 39.52%
2 Materials 10.9%
3 Industrials 10.07%
4 Technology 9.2%
5 Financials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THFF icon
26
First Financial Corp
THFF
$929M
$1.96M 1.75%
42,500
– –
B
27
Barrick Mining
B
$58.4B
$1.94M 1.73%
125,000
– –
FCX icon
28
Freeport-McMoran
FCX
$84.2B
$1.9M 1.7%
50,000
+20,000
+67% +$895K
COHU icon
29
Cohu
COHU
$2.43B
$1.87M 1.67%
70,000
+10,000
+17% +$262K
JAZZ icon
30
Jazz Pharmaceuticals
JAZZ
$15.2B
$1.85M 1.65%
15,000
-5,000
-25% -$589K
EOLS icon
31
Evolus
EOLS
$371M
$1.66M 1.48%
150,000
– –
PAAS icon
32
Pan American Silver
PAAS
$17.7B
$1.62M 1.44%
80,000
+30,000
+60% +$671K
XOMA
33
DELISTED
Xoma
XOMA
$1.45M 1.29%
55,000
– –
ACAD icon
34
Acadia Pharmaceuticals
ACAD
$4.39B
$1.28M 1.15%
70,000
– –
WBA
35
DELISTED
Walgreens Boots Alliance
WBA
$1.17M 1.04%
125,000
-75,000
-38% -$696K
SVC
36
Service Properties Trust
SVC
$1.13B
$1.14M 1.02%
90,000
+30,000
+50% +$485K
ELDN icon
37
Eledon Pharmaceuticals
ELDN
$296M
$1.13M 1.01%
275,000
– –
CVS icon
38
CVS Health
CVS
$136B
$1.12M 1%
25,000
-10,000
-29% -$561K
HAS icon
39
Hasbro
HAS
$11.6B
$1.12M 1%
+20,000
New +$1.31M
HRTX icon
40
Heron Therapeutics
HRTX
$90.1M
$1.07M 0.96%
700,000
+200,000
+40% +$324K
DIT icon
41
AMCON Distributing
DIT
$66.9M
$1.07M 0.95%
12,500
– –
AVIR icon
42
Atea Pharmaceuticals
AVIR
$377M
$1M 0.9%
300,000
+30,000
+11% +$99.7K
COYA icon
43
Coya Therapeutics
COYA
$108M
$917K 0.82%
160,000
+15,941
+11% +$109K
WBD icon
44
Warner Bros
WBD
$68.4B
$740K 0.66%
70,000
-105,000
-60% -$976K
NKTR icon
45
Nektar Therapeutics
NKTR
$2.27B
$698K 0.62%
50,000
– –
CRIS icon
46
Curis
CRIS
$9.71M
$673K 0.6%
11,000
+5,000
+83% +$429K
LTRN icon
47
Lantern Pharma
LTRN
$37.1M
$638K 0.57%
200,000
+15,000
+8% +$51.4K
CTSO icon
48
Cytosorbents Corp
CTSO
$23.2M
$637K 0.57%
700,000
-100,000
-13% -$98.1K
OSTX
49
OS Therapies Inc
OSTX
$66.8M
$471K 0.42%
110,044
+60,044
+120% +$176K
FEMY icon
50
Femasys
FEMY
$9.21M
$468K 0.42%
21,250
– –
1
2
3

Similar funds

AA
Ahara Advisors Jersey City, New Jersey $120M AUM
CC
Commons Capital Needham, Massachusetts $120M AUM 31.45% 1-Year Est. Return
DG
Dala Group Hoffman Estates, Illinois $120M AUM
ACM
AIHC Capital Management Central $120M AUM
WAG
Windsor Advisory Group Columbus, Ohio $120M AUM 4.29% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
IW
Integrated Wealthcare Durham, North Carolina $120M AUM
BCWM
Ball & Co Wealth Management Franklin, Tennessee $120M AUM 21.28% 1-Year Est. Return

CM Management's Q4 2024 Portfolio in Review

As of Q4 2024, CM Management held 66 positions worth $112M, down 11% from $125M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

CM Management withdrew a net $5.94M in Q4 2024, closing 9 positions and reducing 11 holdings. Its most notable exit was Kyndryl, an estimated $3.22M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 40% a quarter earlier, followed by Materials and Industrials.

Against the trend, CM Management opened a new position in Hasbro worth $1.12M.

  • CM Management's largest Q4 2024 buy was Hasbro: 20,000 shares worth $1.12M.
  • CM Management added most to Copa Holdings in Q4 2024, an estimated $1.19M increase.
  • CM Management's biggest Q4 2024 reduction was Warner Bros, cutting an estimated $976K.
  • CM Management fully exited Kyndryl in Q4 2024, selling an estimated $3.22M.
  • CM Management's ten largest holdings make up 39% of its $112M portfolio in Q4 2024.
  • CM Management opened 2 new positions and closed 9 in Q4 2024.
  • CM Management's portfolio value fell 11% quarter-over-quarter to $112M.

Based on CM Management's 13F filing for Q4 2024, filed 7 Feb 2025.